Bergerheim US - Search Results

1

Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization.

Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim US. Matsuyama H, et al. Among authors: bergerheim us. Oncogene. 1994 Oct;9(10):3071-6. Oncogene. 1994. PMID: 8084616

2

Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.

Matsuyama H, Pan Y, Yoshihiro S, Kudren D, Naito K, Bergerheim US, Ekman P. Matsuyama H, et al. Among authors: bergerheim us. Prostate. 2003 Feb 1;54(2):103-11. doi: 10.1002/pros.10173. Prostate. 2003. PMID: 12497583

3

Chromosomal numerical aberrations detected by fluorescence in situ hybridization on bladder washings from patients with bladder cancer.

Marano A, Pan Y, Li C, Pagliarulo A, Elmberger G, Tribukait B, Ekman P, Bergerheim U. Marano A, et al. Eur Urol. 2000 Mar;37(3):358-65. doi: 10.1159/000052370. Eur Urol. 2000. PMID: 10720866

4

Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade.

Mahdy E, Pan Y, Wang N, Malmström PU, Ekman P, Bergerheim U. Mahdy E, et al. Anticancer Res. 2001 Sep-Oct;21(5):3167-73. Anticancer Res. 2001. PMID: 11848469

5

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

Bergerheim US, Kunimi K, Collins VP, Ekman P. Bergerheim US, et al. Genes Chromosomes Cancer. 1991 May;3(3):215-20. doi: 10.1002/gcc.2870030308. Genes Chromosomes Cancer. 1991. PMID: 1868037

6

Nonrandom numerical aberrations of chromosomes 7, 9, and 10 in DNA-diploid bladder cancer.

Matsuyama H, Bergerheim US, Nilsson I, Pan Y, Skoog L, Tribukait B, Ekman P. Matsuyama H, et al. Among authors: bergerheim us. Cancer Genet Cytogenet. 1994 Oct 15;77(2):118-24. doi: 10.1016/0165-4608(94)90226-7. Cancer Genet Cytogenet. 1994. PMID: 7954321

7

Identification of two distinct deleted regions on chromosome 13 in prostate cancer.

Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G, Bergerheim US. Li C, et al. Among authors: bergerheim us. Oncogene. 1998 Jan 29;16(4):481-7. doi: 10.1038/sj.onc.1201554. Oncogene. 1998. PMID: 9484837

8

Chromosome 16q24 deletion and decreased E-cadherin expression: possible association with metastatic potential in prostate cancer.

Pan Y, Matsuyama H, Wang N, Yoshihiro S, Häggarth L, Li C, Tribukait B, Ekman P, Bergerheim US. Pan Y, et al. Among authors: bergerheim us. Prostate. 1998 Jun 15;36(1):31-8. doi: 10.1002/(sici)1097-0045(19980615)36:1<31::aid-pros5>3.0.co;2-e. Prostate. 1998. PMID: 9650913 Clinical Trial.

9

Deletions on chromosome 8p22 may predict disease progression as well as pathological staging in prostate cancer.

Matsuyama H, Pan Y, Oba K, Yoshihiro S, Matsuda K, Hägarth L, Kudren D, Naito K, Bergerheim US, Ekman P. Matsuyama H, et al. Among authors: bergerheim us. Clin Cancer Res. 2001 Oct;7(10):3139-43. Clin Cancer Res. 2001. PMID: 11595707

10

The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer.

Matsuyama H, Pan Y, Oba K, Yoshihiro S, Matsuda K, Hägarth L, Kudren D, Naito K, Bergerheim US, Ekman P. Matsuyama H, et al. Among authors: bergerheim us. Aktuelle Urol. 2003 Jul;34(4):247-9. doi: 10.1055/s-2003-41607. Aktuelle Urol. 2003. PMID: 14566675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters